Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Inari Medical Inc (NARI) stock saw a modest uptick, ending the day at $79.74 which represents a slight increase of $0.28 or 0.35% from the prior close of $79.46. The stock opened at $79.54 and touched ...

UroMems, a global medical technology company developing the first smart automated implant to treat stress urinary incontinence (SUI), announced today that Dan Rose has been appointed as the new ...

Inari Medical (TASE:PMCN) Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the $4.68 billion medical device company.

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Danielle Antalffy; Analyst; UBS Equities Michael Polark; Analyst; Wolfe Research ...

In a report released today, Josh Jennings from TD Cowen reiterated a Buy rating on Stryker (SYK – Research Report), with a price target of ...

US Dollar South African Rand, S&P 500, Intel Corporation, Microsoft Corporation. Read Vestact 's latest article on Investing.com South Africa.

NextEra Energy, Oracle Corp and Stryker led the charge in US investment-grade corporate bonds this week, offering ...